Novel percutaneous left atrial appendage closure

Cardiovascular Revascularization Medicine

Volumn 14, Issue 3, 2013, Pages 164-167

  Bruce, Charles J ^a   Asirvatham, Samuel J ^a   McCaw, Trevor ^b   Hong, Eliot ^b   Berhow, Steven ^b   Ammash, Naser M ^a   Friedman, Paul A ^a  

^a MAYO CLINIC   (United States)

^b Aegis Medical Inc   (United States)

Author keywords

Atrial fibrillation; Innovation; Left atrial appendage closure; Ligation; Stroke

Indexed keywords

APIXABAN; DABIGATRAN; RIVAROXABAN;

DOPPLER ECHOCARDIOGRAPHY; ELECTROGRAPHY; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LIGATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANIMALS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC CATHETERS; DOGS; EQUIPMENT DESIGN; HUMANS; MODELS, ANIMAL; STROKE; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 84879273089     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.04.001     Document Type: Review

References (18)

1. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001, 37:371-378.
2. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114:119-125.
3. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
4. Blackshear J.L., Johnson W.D., Odell J.A., et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003, 42:1249-1252.
5. Blackshear J.L., Odell J.A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996, 61:755-759.
6. Camm A.J., Lip G.Y., De Caterina R., et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012, 33:2719-2747.
7. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e257-e354.
8. Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009, 374:534-542.
9. Singh I.M., Holmes D.R. Left atrial appendage closure. Curr Cardiol Rep 2010, 12:413-421.
10. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009, 361:1139-1151.
11. Granger C.B., Alexander J.H., McMurray J.J., et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011, 365:981-992.
12. Patel M.R., Mahaffey K.W., Garg J., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365:883-891.
13. Holmes D. Randomized trial of LAA closure vs warfarin for stroke/thromboembolic prevention in patients with non-valvular atrial fibrillation (PREVAIL). Am Coll Cardiol Sci Sessions 2013.
14. Reddy V.Y., Holmes D., Doshi S.K., Neuzil P., Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011, 123:417-424.
15. Bartus K., Han F.T., Bednarek J., et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 2012.
16. Friedman P.A., Asirvatham S.J., Dalegrave C., et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol 2009, 20:908-915.
17. Sosa E., Scanavacca M., d'Avila A. Gaining access to the pericardial space. Am J Cardiol 2002, 90:203-204.
18. Bruce C.J., Stanton C.M., Asirvatham S.J., et al. Percutaneous epicardial left atrial appendage closure: intermediate-term results. J Cardiovasc Electrophysiol 2011, 22:64-70.